Floatz logo

BMS-986345

Recurrent Chronic Lymphocytic Leukemia

City of Hope Medical CenterPhase 2Active
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
35/ 100
Competitive Position
81/ 100

Competitive context

28 Active assets in the Recurrent Chronic Lymphocytic Leukemia cohort.

Asset / SponsorPhaseRating
Fludarabine
Ohio State University Comprehensive Cancer Center
Phase 4BBB
Cyclophosphamide
Ohio State University Comprehensive Cancer Center
Phase 4BBB
Inno-206
Zulfa Omer
Phase 4BB
PREDNISONE TABLETS
Zulfa Omer
Phase 4BB
DEXAMETHASONE
Vitebsk Regional Clinical Cancer Centre
Phase 3BB

View all 50 →

Same molecule, other indications

BMS-986345 is also rated in:

Chronic Lymphocytic LeukemiaDormant
B
Indicative ·
58 / 100
View asset →
Follicular LymphomaDormant
B
Indicative ·
56 / 100
View asset →
Indolent Non-Hodgkin LymphomaDormant
B
Indicative ·
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →